Lewis Clayton Cantley Jr., Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 2,504 shares at $44.33 ($107K) on 2016-01-28, disclosed to the SEC on 2016-02-01.
Scheduled sale ($107k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.33 | 625 | $28K | 25.8% |
| 2 | $44.33 | 627 | $28K | 25.9% |
| 3 | $41.52 | 625 | $26K | 24.1% |
| 4 | $41.52 | 627 | $26K | 24.2% |
| Total | $42.93 avg | 2,504 | $107K | 100% |
| Filing → |
| AGIO | SELL | 2017-10-18 | $142K | — | Filing → |
| AGIO | SELL | 2017-09-15 | $131K | — | Filing → |
| AGIO | SELL | 2017-08-24 | $114K | — | Filing → |